Navigation Links
Erectile dysfunction lower in men who have intercourse more often
Date:7/2/2008

New York, July 1, 2008 Having intercourse more often may help prevent the development of erectile dysfunction (ED). A study published in the July 2008 issue of The American Journal of Medicine reports that researchers have found that men who had intercourse more often were less likely to develop ED.

Analyzing a five-year study of 989 men aged 55 to 75 years from Pirkanmaa, Finland, the investigators observed that men reporting intercourse less than once per week at baseline had twice the incidence of erectile dysfunction compared with those reporting intercourse once per week. Further, the risk of erectile dysfunction was inversely related to the frequency of intercourse.

Other factors that may affect the incidence of ED, such as age, chronic medical conditions (diabetes, heart disease, hypertension, cerebrovascular disease and depression), body mass index and smoking were included in the analysis of the data.

Erectile dysfunction incidence was 79 cases per 1000 in men who had reported sexual intercourse less than once per week, dropping to 32 cases per 1000 in men reporting intercourse once per week and falling further to 16 per 1000 in those reporting intercourse 3 or more times per week.

In addition, the frequency of morning erections predicted the development of complete erectile dysfunction, with an approximate 2.5-fold risk among those with less than 1 morning erection per week compared with 2 to 3 morning erections per week

Writing in the article, Juha Koskimki, MD, PhD, Tampere University Hospital, Department of Urology, Tampere, Finland, states; "Regular intercourse has an important role in preserving erectile function among elderly men, whereas morning erection does not exert a similar effect. Continued sexual activity decreases the incidence of erectile dysfunction in direct proportion to coital frequency."

The study clearly indicates that regular intercourse protects men from the develo
'/>"/>

Contact: Pamela Poppalardo
ajmmedia@elsevier.com
212-633-3944
Elsevier Health Sciences
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Gene Therapy May Treat Erectile Dysfunction
2. Erectile Dysfunction a Strong Harbinger of Heart Trouble
3. AUA 2008: Maxi-K gene transfer may prove to be safe and effective erectile dysfunction treatment
4. The Penis Diet: A Healthy Solution for Men Challenged by Erectile Dysfunction
5. FDA Approves Cialis(R) (tadalafil) for Once Daily Use for the Treatment of Erectile Dysfunction
6. Horphags Prelox(R) Provides Over-the-Counter Solution in Battle Against Erectile Dysfunction
7. Warner Chilcott and NexMed Sign U.S. Collaboration for Topical Alprostadil Treatment for Erectile Dysfunction
8. Diabetic Men With Erectile Dysfunction Urged to Consult Their Doctors During November - American Diabetes Month
9. Erectile Dysfunction: A Harbinger of Heart Trouble
10. Cialis Eases Erectile Dysfunction After Spinal Cord Injury
11. Acupuncture reduces pain and dysfunction in head and neck cancer patients after neck dissection

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)...ld identify those who would benefit from liver sur...DAY, Dec. 1 (HealthDay News) -- A CT scan of liver...may help predict overall survival after chemothera...vastin) to cytotoxic chemotherapy has been shown t...orectal cancer and to produce better results in pa...
(Date:12/1/2009)...HILADELPHIA (December 1, 2009) Wistar Institute ...of Pennsylvania and New York University have ident...icate early-stage lung tumors in people at high ri...shed online December 1 in Cancer Research , a jou...ch, could lead to a simple blood test to detect lu...
(Date:12/1/2009)... Ever thought you could quit...Kevin Arthur Smith,s groundbreaking new system for... permanent. In just twenty eight days your craving..., (PRWEB) December 1, 2009...ing her eight-year addiction to nicotine, smoking ...
(Date:12/1/2009)... , LEHIGH VALLEY, Pa., Dec. 1 /PRNewswire-Fi... it has completed the previously announced sale of...ess, marketed under the Airthane® and Versath...ed subsidiary of global polyurethane chemicals pro...r Products, manufacturing facility in Paulsboro, N...
(Date:12/1/2009)... , WASHINGTON, Dec. 1 /PRNewswire-USNewswire/...ency for International Development: ,, Chairman...ommittee. ,, I am honored to be nominated by Pr...ted States Agency for International Development, a...gency. ,, Secretary of State Clinton has expre...
Breaking Medicine News(10 mins):Health News:CT Scan May Predict Colon Cancer Survival 2Health News:Wistar-led research team discovers genetic pattern that indicates early-stage lung cancer 2Health News:Wistar-led research team discovers genetic pattern that indicates early-stage lung cancer 3Health News:Former Cigarette Dealer Sells Business in Order to Fund Quit Smoking Book 2Health News:Former Cigarette Dealer Sells Business in Order to Fund Quit Smoking Book 3Health News:Air Products Completes Sale of Polyurethane Pre-Polymers Business to COIM USA 2Health News:Testimony Before the Senate Committee on Foreign Relations Administrator Designate Dr. Rajiv Shah December 1, 2009 2Health News:Testimony Before the Senate Committee on Foreign Relations Administrator Designate Dr. Rajiv Shah December 1, 2009 3Health News:Testimony Before the Senate Committee on Foreign Relations Administrator Designate Dr. Rajiv Shah December 1, 2009 4Health News:Testimony Before the Senate Committee on Foreign Relations Administrator Designate Dr. Rajiv Shah December 1, 2009 5Health News:Testimony Before the Senate Committee on Foreign Relations Administrator Designate Dr. Rajiv Shah December 1, 2009 6Health News:Testimony Before the Senate Committee on Foreign Relations Administrator Designate Dr. Rajiv Shah December 1, 2009 7Health News:Testimony Before the Senate Committee on Foreign Relations Administrator Designate Dr. Rajiv Shah December 1, 2009 8Health News:Testimony Before the Senate Committee on Foreign Relations Administrator Designate Dr. Rajiv Shah December 1, 2009 9
... Demonstrated, ROCKVILLE, Md., Dec. 10 EntreMed,...tical company developing,therapeutics for the trea...nnounced the presentation of preclinical results i... Dr. Maria,Kavallaris, at the American Society of ...
...ehabilitation and the University of Florida have r...n the Brooks Center for Rehabilitation Studies,in ...acility., The agreement increases funding for the...through its Health,Science Center colleges, will p...
...oVaccine Technologies Inc. (IVT),a Nova Scotia-bas...ng,memorandum of understanding to acquire Immunoto...y developing immunotherapy products,for the treatm...tfolio of immunotherapeutic antigens and,antigen d...
...os Addresses Objectives from the Joint, Commission...and Institute for Healthcare... National Forum on,Quality Improvement in Health C...egulations Package, a comprehensive,compilation of...
...he nation,s leading,supplier of replacement medica...ognized as a 2007 Pillar Award winner for communit...that have distinguished themselves,through leading...resources to help people around the world receive ...
...to be held Thursday, January 17, at ...Calif., Dec. 10 Cardica, Inc.,(Nasdaq: CRDC ) to...he Heart,Hospital Baylor Plano and Centennial Medi...ng innovative anastomotic,devices from Cardica, In...
Other Medicine News:Health News:EntreMed Presents Results for ENMD-1198 and Vincristine in Preclinical Leukemia Models 2Health News:EntreMed Presents Results for ENMD-1198 and Vincristine in Preclinical Leukemia Models 3Health News:Brooks and the University of Florida Reach Research Agreement 2Health News:ImmunoVaccine Technologies Inc. to Acquire Immunotope Inc. 2Health News:GetWellNetwork Offers Comprehensive Education Package Enabling Hospitals to Meet Compliance Requirements for Patient Education 2Health News:GetWellNetwork Offers Comprehensive Education Package Enabling Hospitals to Meet Compliance Requirements for Patient Education 3Health News:GetWellNetwork Offers Comprehensive Education Package Enabling Hospitals to Meet Compliance Requirements for Patient Education 4Health News:Cardica Announces Live Webcast Demonstrating Breakthrough Device to Facilitate Beating Heart and Robotic Coronary Revascularization Surgery 2Health News:Cardica Announces Live Webcast Demonstrating Breakthrough Device to Facilitate Beating Heart and Robotic Coronary Revascularization Surgery 3Health News:Cardica Announces Live Webcast Demonstrating Breakthrough Device to Facilitate Beating Heart and Robotic Coronary Revascularization Surgery 4Health News:Cardica Announces Live Webcast Demonstrating Breakthrough Device to Facilitate Beating Heart and Robotic Coronary Revascularization Surgery 5
(Date:12/1/2009)...RRY HILL, N.J., Dec. 1 F...rprised and delighted when his radiotherapy treatm...0 minutes each day to less than five. Midway thro...are Valley Urology Cancer Center acquired the re...gy from Varian Medical Systems (NYSE: VAR ), ma...
(Date:12/1/2009)... Calif., Dec. 1 The new position o...Microchip Biotechnologies, Inc. has been taken up ...ve with more than 30 years of experience creating ...r. Goldstein will direct Microchip Biotechnologies...mer service operations as the company makes the tr...
(Date:12/1/2009)... and TOKYO, Dec. 1 Galenea Corp. a... the further extension of their research and devel...tension increases the collaboration term to seven ...proximately $90 million. The companies have been ...of discovering and developing first-in-class thera...
Breaking Medicine Technology:Fighting Prostate Cancer With Speed and Accuracy: RapidArc(R) Radiotherapy Available at the Delaware Valley Urology Cancer Treatment Center 2Fighting Prostate Cancer With Speed and Accuracy: RapidArc(R) Radiotherapy Available at the Delaware Valley Urology Cancer Treatment Center 3Fighting Prostate Cancer With Speed and Accuracy: RapidArc(R) Radiotherapy Available at the Delaware Valley Urology Cancer Treatment Center 4Fighting Prostate Cancer With Speed and Accuracy: RapidArc(R) Radiotherapy Available at the Delaware Valley Urology Cancer Treatment Center 5Howard Goldstein Joins Microchip Biotechnologies, Inc. as Executive Vice President 2Galenea and Otsuka Announce Second Extension to Schizophrenia Research Collaboration 2Galenea and Otsuka Announce Second Extension to Schizophrenia Research Collaboration 3First Pediatric Patient Treated With Aptocine 28TM 29 a Novel Light Activated Drug in Neurofibromatosis Study 13528 1First Pediatric Patient Treated With Aptocine 28TM 29 a Novel Light Activated Drug in Neurofibromatosis Study 13528 2First Pediatric Patient Treated With Aptocine 28TM 29 a Novel Light Activated Drug in Neurofibromatosis Study 13528 3Sage Software Healthcare Inc Celebrates National Health Center Week 54311 1Sage Software Healthcare Inc Celebrates National Health Center Week 54311 2Goold Health Systems Accelerates Backups by 5 times Using Arkeia Network Backup 54309 1Goold Health Systems Accelerates Backups by 5 times Using Arkeia Network Backup 54309 2Goold Health Systems Accelerates Backups by 5 times Using Arkeia Network Backup 54309 3
...allisto Pharmaceuticals,Inc. (Amex: KAL; FWB: CA4)...against cancer and inflammatory diseases, announce...clinical trial of Atiprimod to treat low to,interm...rcinoid cancer).,With the addition of the Robert H...n University, 676 N. St. Clair Street, Suite 850, ...
... Give Molecular Laboratories Increased Efficiencie... Test, Which Surpasses, Standard-of-Care Sensitiv... Measure All Known Strains of HIV-1,...has received a supplemental Premarket Approval fro...cently introduced RealTime HIV-1 viral load test.,...
Other Medicine Technology:Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients 2Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients 3Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients 4Abbott Receives Supplemental FDA Approval for its Best-in-Class in Sensitivity RealTime HIV-1 Viral Load Test 2Abbott Receives Supplemental FDA Approval for its Best-in-Class in Sensitivity RealTime HIV-1 Viral Load Test 3Abbott Receives Supplemental FDA Approval for its Best-in-Class in Sensitivity RealTime HIV-1 Viral Load Test 4Abbott Receives Supplemental FDA Approval for its Best-in-Class in Sensitivity RealTime HIV-1 Viral Load Test 5Abbott Receives Supplemental FDA Approval for its Best-in-Class in Sensitivity RealTime HIV-1 Viral Load Test 6
...rosol Resistant Tips offer a safe alternative to u... designed for applications such as PCR(a), pipetti...ddition, ART Tips are excellent for tissue culture...dies. ART Tips prevent aerosol contaminants and li...
Tipack (Sterilized) D1000
MBP 1000GGenomic Tip
...Premium Low Binding, Graduated, Long Reach Pipet T...d protein binding. Non-reactive. Beveled and refer...s up to 10 L. Produced & packaged completely by au...e Racked packaged 96 tips/rack and 10 racks/cs. AV...
Medicine Products: